Contract 75N90023P00746
Diasorin Inc · Department Of Health And Human Services · September 25, 2024
Diasorin Inc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 25, 2024 for $152,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Bethesda, MD. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on August 21, 2025. If all options are exercised, the contract could reach $536,000.
Contract details
- PIID
- 75N90023P00746
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Laboratory Equipment And Supplies
- Place of performance
- Bethesda, MD
- First action
- September 25, 2024
- Latest action
- August 21, 2025
Description
EXERCISE OPTION YEAR 2
Modification timeline
-
August 21, 2025Mod P00005 · Exercise An Option$536.4K
-
September 25, 2024Mod P00004 · Other Administrative ActionTHE PURPOSE OF THIS MODIFICATION IS TO UPDATE EQUIPMENT THAT HAS BEEN REPLACED.$384.3K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Biomerieux Inc | Department Of Health And Human Services | March 31, 2026 | $0 |
| Beckman Coulter, Inc. | Department Of Health And Human Services | March 30, 2026 | $80.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Biomerieux Inc | 182 | $25.50M |
| 2 | Cepheid | 114 | $20.70M |
| 3 | Roche Diagnostics Corporation | 125 | $13.00M |
| 4 | Quest Diagnostics Incorporated | 8 | $4.31M |
| 5 | Hologic Sales And Service, Llc | 39 | $3.88M |
| 6 | Beckman Coulter, Inc | 28 | $3.40M |
| 7 | Fisher Scientific Company L.L.C. | 52 | $3.04M |
| 8 | Werfen USA Llc | 91 | $2.75M |
| 9 | Diasorin Inc | 21 | $2.74M |
| 10 | Abbott Laboratories Inc. | 10 | $2.69M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N90023P00746?
Contract 75N90023P00746 is a federal contract awarded to Diasorin Inc by Department Of Health And Human Services on September 25, 2024 for $152,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 75N90023P00746?
Diasorin Inc won contract 75N90023P00746 from Department Of Health And Human Services.
How much is contract 75N90023P00746 worth?
Contract 75N90023P00746 has obligated $152,000 to date, with a total potential value of $536,000 if all options are exercised.